PsyBio Therapeutics Corp Ordinary Shares PSYBF
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Shares Outstanding
- 127.54M
- Market Cap
- $127.54
- Volume/Avg
- 12,500 / 5,851
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 4
- Website
- https://www.psybiolife.com
Valuation
|
Metric
|
PSYBF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PSYBF
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.05 |
Interest Coverage | −211.78 |
Quick Ratio
PSYBF
Profitability
|
Metric
|
PSYBF
|
|---|---|
Return on Assets (Normalized) | −449.23% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
PSYBF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|K%y%JG | LOCK|tSn#m | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|^sLb#b | LOCK|YpMj& | $83B | |||
| Moderna Inc
MRNA
| LOCK|h<#s@vS | LOCK|sf | $80B | |||
| argenx SE ADR
ARGX
| LOCK|$X#$Qt | LOCK|&^ | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|F!y^yGK | LOCK|Jqd | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|FlMX?B | LOCK|>xz% | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|Z#^QhC> | LOCK|^MM%N | $28B | |||
| Incyte Corp
INCY
| LOCK|SSrVxN? | LOCK|V@ | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|sMf$HsP | LOCK|c& | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|BXN!rD | LOCK|&> | $14B |
United States